Effectiveness of Astym Treatment For de Quervain's Tenosynovitis

Completed · Not applicable

Conditions studied: de Quervain's Disease

In brief

To determine if the addition of Astym treatment to traditional therapy produces a more positive outcome then traditional therapy alone for the treatment of de Quervain's tenosynvitis. Two groups will be examined with one group receiving traditional therapy and the other group receiving traditional therapy in addition to Astym treatment protocol.

Key facts

Study ID: NCT02442622
Run by: NYU Langone Health
People needed: 32
Starts: 2015-01-01
Expected to finish: 2019-04-29
Last updated by the study team: 2020-10-09

Who can join

Age: 18 and older, up to 65. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

i. Positive Finkelstein's test: The client will report pain over the first compartment of the extensor retinaculum when the thumb is tucked in the hand and deviated ulnarly.
ii. Persistent symptoms for >3 wks which have not resolved after an additional 3 weeks of splinting
iii. A diagnosis by a physician of "de Quervain's", "fist compartment tenosynovitis", or "radial styloid tenosynovitis"
iv. Patients must agree and comply to a predetermined splinting regimen

You may not qualify if…

i. History of cortical steroid injection to affected wrist and/or thumb
ii. History of previous wrist trauma to affected limb
iii. Comorbidity such as carpal tunnel syndrome (CTS), radial tunnel syndrome, osteoarthritis, rheumatoid arthritis, auto-immune disease or inflammatory conditions, lateral epicondylitis or tendinopathies
iv. Clotting deficits
v. Positive Cozen's sign which would indicate intersection syndrome
vi. Post-partum mothers <6 months and pregnant women

Where it is running

NYU Langone Medical Center, Center for Musculoskeletal Care — New York, New York, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.